Skip to content
OpenCapital
Collapse sidebar
Watchlist
Screener
Filings
Earnings
Charts
Collapse sidebar
Screener
GoodRx Holdings, Inc.
GDRX
Selling Expense
Selling Expense at other companies
Abercrombie & Fitch
ANF
$431.2M
+7.8%
OFL
Omega Flex
OFLX
$5.49M
+9.9%
JAK
Jakks Pacific
JAKK
$8.16M
-6.1%
Alaska Air Group
ALK
$115M
+9.5%
Lindsay Corporation
LNN
$10.32M
+1.0%
CVD Equipment Corp.
CVV
$240K
-34.6%
Segments
By product
See full
Prescription transactions revenue
$11.2M
-2.6%
Other financials
Income statement
See full
Revenue
$200.4M
-1.3%
Gross profit
$179.4M
-5.4%
Operating income
$23.6M
-11.9%
Net income
$8.5M
-33.5%
EPS (diluted)
$0.02
-50.0%
Balance sheet
See full
Cash & equivalents
$296.1M
+5.3%
Total debt
$539.0M
-1.6%
Total equity
$647.6M
+0.7%
Total assets
$2.3B
+77.7%
Cash flow
See full
Operating cash flow
$80.8M
+63.0%
CapEx
$362.0K
-7.2%
Free cash flow
$80.5M
+63.6%
Valuation
See full
Market cap
$1.26B
+3.8%
Enterprise value
$1.5B
+1.6%
P/E
77.3×
+42.3×
P/S
1.6×
+0.1×
Profitability
See full
Gross margin
90.8%
-2.8pp
Operating margin
9.5%
-1.6pp
Net margin
2.1%
-2.3pp
FCF margin
25.1%
+1.4pp
Returns & leverage
See full
Return on equity
2.5%
-2.8pp
Debt / equity
0.8×
0.0×
Current ratio
1.4×
-2.8×
Watchlist
Screener
Filings
Earnings
Charts